Evaluation of the efficacy, safety and glycaemic effects of evolocumab (AMG 145) in hypercholesterolaemic patients stratified by glycaemic status and metabolic syndrome. (Diabetes, Obesity and Metabolism, 2016)

(untitled) - Blom, D; Koren, M; Roth, E; Monsalvo, M; Djedjos, C; Nelson, P; Elliott, M; Wasserman, S; Ballantyne, C; Holman, R